MAML3 and acute myeloid leukemia: Moreover, we found that OS was significantly lower among AML patients with high expression of MAML3 or PLCB1, calculated by the online survival analysis tool “Kaplan-Meier Plotter” (KM plotter) database, including GSE1159, GSE12417, GSE37642, GSE6891 and GSE8970 datasets (Fig. 4K).